Lv3
326 积分 2025-03-15 加入
Mirdametinib approval for neurofibromatosis type 1 with inoperable plexiform neurofibromas: the journey of MEK inhibitors
25天前
已完结
Decreased LONP1 expression exacerbates MASH-induced liver fibrosis via elevated orotic acid levels
30天前
已完结
Tirzepatide for Metabolic Dysfunction–Associated Steatohepatitis with Liver Fibrosis
30天前
已完结
A Phase 3, Randomized, Controlled Trial of Resmetirom in NASH with Liver Fibrosis
30天前
已完结
Antifibrotic therapy in nonalcoholic steatohepatitis: time for a human-centric approach
30天前
已完结
Neutrophil extracellular traps promote MASH fibrosis by metabolic reprogramming of HSC
30天前
已完结
Cellular stress in the pathogenesis of nonalcoholic steatohepatitis and liver fibrosis
30天前
已完结
Hepatic inflammatory responses in liver fibrosis
30天前
已完结
Mechanisms of hepatic stellate cell activation
30天前
已完结
Mechanisms of Fibrosis Development in Nonalcoholic Steatohepatitis
30天前
已完结
皖公网安备34019202002308
